The RNA-editing Enzyme APOBEC1 Requires heterogeneous nuclear ribonucleoprotein Q Isoform 6 for efficient interaction with interleukin-8 mRNA

Journal of Biological Chemistry

Volumn 289, Issue 38, 2014, Pages 26226-26238

  Shimizu, Yuko ^a   Nishitsuji, Hironori ^a   Marusawa, Hiroyuki ^b   Ujino, Saneyuki ^a   Takaku, Hiroshi ^c   Shimotohno, Kunitada ^a  

^a National Center for Global Health and Medicine   (Japan)

^b KYOTO UNIVERSITY   (Japan)

^c CHIBA INSTITUTE OF TECHNOLOGY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BIOCHEMISTRY; BIOLOGY;

COMPLEMENTATION; EFFICIENT INTERACTION; INTERLEUKIN-8; ISOFORMS; NUCLEAR RIBONUCLEOPROTEIN; TARGET GENES; TARGET SELECTION;

NUCLEIC ACIDS;

APOLIPOPROTEIN B MESSENGER RNA EDITING ENZYME CATALYTIC POLYPEPTIDE 1; HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEIN; HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEIN Q6; INTERLEUKIN 8; MESSENGER RNA; SMALL INTERFERING RNA; UNCLASSIFIED DRUG; 3' UNTRANSLATED REGION; APOLIPOPROTEIN B MRNA EDITING ENZYME; CYTIDINE DEAMINASE; ISOPROTEIN; PROTEIN BINDING; SYNCRIP PROTEIN, HUMAN;

3' UNTRANSLATED REGION; ARTICLE; CELL LYSATE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DNA MICROARRAY; GENE OVEREXPRESSION; GENE TARGETING; HEK293 CELL LINE; HEPATOCELLULAR CARCINOMA CELL LINE; HUMAN; HUMAN CELL; IL8 GENE; IMMUNOPRECIPITATION; LUCIFERASE ASSAY; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN METABOLISM; PROTEIN PROTEIN INTERACTION; PROTEIN STABILITY; TWO HYBRID SYSTEM; GENETIC TRANSCRIPTION; GENETICS; HALF LIFE TIME; METABOLISM; POINT MUTATION; RNA STABILITY; TRANSCRIPTION INITIATION; TUMOR CELL LINE;

3' UNTRANSLATED REGIONS; CELL LINE, TUMOR; CYTIDINE DEAMINASE; HALF-LIFE; HEK293 CELLS; HETEROGENEOUS-NUCLEAR RIBONUCLEOPROTEINS; HUMANS; INTERLEUKIN-8; POINT MUTATION; PROTEIN BINDING; PROTEIN ISOFORMS; RNA STABILITY; RNA, MESSENGER; TRANSCRIPTION, GENETIC; TRANSCRIPTIONAL ACTIVATION; TWO-HYBRID SYSTEM TECHNIQUES;

EID: 84907192457     PISSN: 00219258     EISSN: 1083351X     Source Type: Journal    
DOI: 10.1074/jbc.M114.563221     Document Type: Article

References (28)

1. Greeve, J., Altkemper, I., Dieterich, J. H., Greten, H., and Windler, E. (1993) Apolipoprotein B mRNA editing in 12 different mammalian species: hepatic expression is reflected in low concentrations of apoB-containing plasma lipoproteins. J. Lipid Res. 34, 1367-1383
2. Morrison, J. R., Pászty, C., Stevens, M. E., Hughes, S. D., Forte, T., Scott, J., and Rubin, E. M. (1996) Apolipoprotein B RNA editing enzyme-deficient mice are viable despite alterations in lipoprotein metabolism. Proc. Natl. Acad. Sci. U.S.A. 93, 7154-7159
3. Shah, R. R., Knott, T. J., Legros, J. E., Navaratnam, N., Greeve, J. C., and Scott, J. (1991) Sequence requirements for the editing of apolipoprotein B mRNA. J. Biol. Chem. 266, 16301-16304
4. Richardson, N., Navaratnam, N., and Scott, J. (1998) Secondary structure for the apolipoprotein BmRNAediting site: AU-binding Proteins Interact with a Stem Loop. J. Biol. Chem. 273, 31707-31717
5. Mehta, A., Kinter, M. T., Sherman, N. E., and Driscoll, D. M. (2000) Molecular cloning of Apobec-1 complementation factor, a novel RNA-binding protein involved in the editing of apolipoprotein B mRNA. Mol. Cell. Biol. 20, 1846-1854
6. Lellek, H., Kirsten, R., Diehl, I., Apostel, F., Buck, F., and Greeve, J. (2000) Purification and molecular cloning of a novel essential component of the apolipoprotein B mRNA editing enzyme-complex. J. Biol. Chem. 275, 19848-19856
7. Chester, A., Somasekaram, A., Tzimina, M., Jarmuz, A., Gisbourne, J., OKeefe, R., Scott, J., and Navaratnam, N. (2003) The apolipoprotein B mRNA editing complex performs a multifunctional cycle and suppresses nonsense-mediated decay. EMBO J. 22, 3971-3982
8. Greeve, J., Lellek, H., Apostel, F., Hundoegger, K., Barialai, A., Kirsten, R., Welker, S., and Greten, H. (1999) Absence of APOBEC-1 mediated mRNA editing in human carcinomas. Oncogene 18, 6357-6366
9. Valdmanis, P. N., Roy-Chaudhuri, B., Kim, H. K., Sayles, L. C., Zheng, Y., Chuang, C. H., Caswell, D. R., Chu, K., Zhang, Y., Winslow, M. M., Sweet- Cordero, E. A., and Kay, M. A. (2013) Upregulation of the microRNA cluster at the Dlk1-Dio3 locus in lung adenocarcinoma. Oncogene 10.1038/onc.2013.523
10. Kristensen, D. G., Nielsen, J. E., Jrgensen, A., Skakkebk, N. E., Rajpert- De Meyts, E., and Almstrup, K. (2014) Evidence that active demethylation mechanisms maintain the genome of carcinoma in situ cells hypomethylated in the adult testis. Br. J. Cancer 110, 668-678
11. Chen, X.-J., Mou, X.-Q., Zou, Y.-G., Peng, Z.-Y., Yang, J.-X. (2013) Screening of key genes associated with contused rat spinal cord with DNA microarray. Eur. Rev. Med. Pharmacol. Sci. 17, 2949-2955
12. Ashur-Fabian, O., Har-Zahav, A., Shaish, A., Wiener Amram, H., Margalit, O., Weizer-Stern, O., Dominissini, D., Harats, D., Amariglio, N., and Rechavi, G. (2010) apoB and apobec1, two genes key to lipid metabolism, are transcriptionally regulated by p53. Cell Cycle 9, 3761-3770
13. Yamanaka, S., Balestra, M. E., Ferrell, L. D., Fan, J., Arnold, K. S., Taylor, S., Taylor, J. M., and Innerarity, T. L. (1995) Apolipoprotein B mRNA-editing protein induces hepatocellular carcinoma and dysplasia in transgenic animals. Proc. Natl. Acad. Sci. U.S.A. 92, 8483-8487
14. Yamanaka, S., Poksay, K. S., Arnold, K. S., and Innerarity, T. L. (1997) A novel translational repressormRNAis edited extensively in livers containing tumors caused by the transgene expression of the apoB mRNA-editing enzyme. Genes Dev. 11, 321-333
15. Cappione, A. J., French, B. L., and Skuse, G. R. (1997) A potential role for NF1 mRNA editing in the pathogenesis of NF1 tumors. Am. J. Hum. Genet. 60, 305-312
16. Anant, S., and Davidson, N. O. (2000) An AU-rich sequence element (UUUN[A/U]U) downstream of the edited C in apolipoprotein B mRNA is a high-affinity binding site for Apobec-1: binding of Apobec-1 to this motif in the 3 untranslated region of c-Myc increases mRNA stability. Mol. Cell Biol. 20, 1982-1992
17. Guo, J. U., Su, Y., Zhong, C., Ming, G. L., and Song, H. (2011) Hydroxylation of 5-methylcytosine by TET1 promotes activeDNAdemethylation in the adult brain. Cell 145, 423-434
18. Anant, S., Murmu, N., Houchen, C. W., Mukhopadhyay, D., Riehl, T. E., Young, S. G., Morrison, A. R., Stenson, W. F., and Davidson, N. O. (2004) Apobec-1 protects intestine from radiation injury through posttranscriptional regulation of cyclooxygenase-2 expression. Gastroenterology 127, 1139-1149
19. Aly, H. H., Watashi, K., Hijikata, M., Kaneko, H., Takada, Y., Egawa, H., Uemoto, S., and Shimotohno, K. (2007) Serum-derived hepatitis C virus infectivity in interferon regulatory factor-7-suppressed human primary hepatocytes. J. Hepatol. 46, 26-36
20. Ravet, K., Reyt, G., Arnaud, N., Krouk, G., Djouani, E. B., Boucherez, J., Briat, J. F., and Gaymard, F. (2011) Iron and ROS control of the Down- STream mRNA decay pathway is essential for plant fitness. EMBO J. 31, 175-186
21. Rosenberg, B. R., Hamilton, C. E., Mwangi, M. M., Dewell, S., and Papavasiliou, F. N. (2011) Transcriptome-wide sequencing reveals numerous APOBEC1 mRNA-editing targets in transcript 3 UTRs. Nat. Struct. Mol. Biol. 18, 230-236
22. Blanc, V., Navaratnam, N., Henderson, J. O., Anant, S., Kennedy, S., Jarmuz, A., Scott, J., and Davidson, N. O. (2001) Identification of GRY-RBP as an apolipoprotein B RNA-binding protein that interacts with both Apobec- 1 and Apobec-1 complementation factor to modulate C to U editing. J. Biol. Chem. 276, 10272-10283
23. Quaresma, A. J. C., Oyama, S., Jr., Barbosa, J. A. R. G., and Kobarg, J. (2006) The acidic domain of hnRNPQ (NSAP1) has structural similarity to Barstar and binds to Apobec1. Biochem. Biophys. Res. Commun. 350, 288-297
24. Lau, P. P., Chang, B. H. J., and Chan, L. (2001) Two-hybrid cloning identifies an RNA-binding protein, GRY-RBP, as a component of apobec-1 editosome. Biochem. Biophys. Res. Commun. 282, 977-983
25. Lau, P. P., Zhu, H.-J., Nakamuta, M., and Chan, L. (1997) Cloning of an Apobec-1-binding protein that also interacts with apolipoprotein B mRNA and evidence for its involvement in RNA editing. J. Biol. Chem. 272, 1452-1455
26. Lau, P. P., Villanueva, H., Kobayashi, K., Nakamuta, M., Chang, B. H.-J., and Chan, L. (2001) A DnaJ protein, Apobec-1-binding protein-2, modulates apolipoprotein B mRNA editing. J. Biol. Chem. 276, 46445-46452
27. Anant, S., Henderson, J. O., Mukhopadhyay, D., Navaratnam, N., Kennedy, S., Min, J., and Davidson, N. O. (2001) Novel role for RNA-binding protein CUGBP2 in mammalian RNA editing: CUGBP2 modulates C toU editing of apolipoprotein b mRNA by interacting with APOBEC-1 and ACF, the APOBEC-1 complementation factor. J. Biol. Chem. 276, 47338-47351
28. Lau, P. P., and Chan, L. (2003) Involvement of a chaperone regulator, Bcl2-associated athanogene-4, in apolipoprotein B mRNA editing. J. Biol. Chem. 278, 52988-52996